Serotype distribution and antimicrobial susceptibility of Streptococcus pneumoniae isolates cultured from Japanese adult patients with community-acquired pneumonia in Goto City, Japan.

Autor: Miyazaki T; Nagasaki University, Nagasaki, Japan.; Division of Respirology, Rheumatology, Infectious Diseases, and Neurology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan., van der Linden M; German Reference Laboratory for Streptococci, Department of Medical Microbiology, University Hospital RWTH, Aachen, Germany., Hirano K; Nagasaki University, Nagasaki, Japan.; National Center for Global Health and Medicine, Tokyo, Japan., Maeda T; Nagasaki University, Nagasaki, Japan., Kohno S; Nagasaki University, Nagasaki, Japan., Gonzalez EN; Pfizer Inc., Collegeville, PA, United States., Zhang P; Pfizer Inc., Collegeville, PA, United States., Isturiz RE; Pfizer Inc., Collegeville, PA, United States., Gray SL; Pfizer Inc., Collegeville, PA, United States., Grant LR; Pfizer Inc., Collegeville, PA, United States., Pride MW; Pfizer Inc., Pearl RiverNew York, NY, United States., Gessner BD; Pfizer Inc., Collegeville, PA, United States., Jodar L; Pfizer Inc., Collegeville, PA, United States., Arguedas AG; Pfizer Inc., Collegeville, PA, United States.

Publikováno v: Frontiers in microbiology [Front Microbiol] 2024 Sep 24; Vol. 15, pp. 1458307. Date of Electronic Publication: 2024 Sep 24 (Print Publication: 2024).

Acute otitis media, antimicrobial prescriptions, and medical expenses among children in the United States during 2011-2016.

Autor: Suaya JA; Vaccines Medical Development & Scientific/Clinical Affairs, Pfizer Inc., 235 E 42nd St, New York, NY 10017, USA. Electronic address: Jose.suaya@pfizer.com., Gessner BD; Vaccines Medical Development & Scientific/Clinical Affairs, Pfizer Inc., 500 Arcola Rd., Collegeville, PA 19426, USA. Electronic address: Bradford.Gessner@pfizer.com., Fung S; Global Business Analytics, Vaccines, Pfizer Inc., 500 Arcola Rd., Collegeville, PA 19426, USA. Electronic address: Shirley.Fung@pfizer.com., Vuocolo S; Vaccines Medical Development & Scientific/Clinical Affairs, Pfizer Inc., 500 Arcola Rd., Collegeville, PA 19426, USA. Electronic address: Scott.Vuocolo@pfizer.com., Scaife J; Global Business Analytics, Vaccines, Pfizer Inc., 235 E 42nd St, New York, NY 10017, USA. Electronic address: John.Scaife@pfizer.com., Swerdlow DL; Vaccines Medical Development & Scientific/Clinical Affairs, Pfizer Inc., 500 Arcola Rd., Collegeville, PA 19426, USA. Electronic address: David.Swerdlow@pfizer.com., Isturiz RE; Vaccines Medical Development & Scientific/Clinical Affairs, Pfizer Inc., 500 Arcola Rd., Collegeville, PA 19426, USA. Electronic address: Raul.Isturiz@pfizer.com., Arguedas AG; Vaccines Medical Development & Scientific/Clinical Affairs, Pfizer Inc., 500 Arcola Rd., Collegeville, PA 19426, USA. Electronic address: Adriano.Arguedas@pfizer.com.

Publikováno v: Vaccine [Vaccine] 2018 Nov 26; Vol. 36 (49), pp. 7479-7486. Date of Electronic Publication: 2018 Oct 24.

Study of antibiotic susceptibility pattern of the isolated organisms in otitis media.

Autor: Lokhande, Ujwala A.¹, Akulwar, Suresh L.², Lokhande, Annasaheb³ aelokhande@gmail.com

Publikováno v: Asian Journal of Medical Sciences. Mar2024, Vol. 15 Issue 3, p179-185. 7p.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Population pharmacokinetics of voriconazole and the role of CYP2C19 genotype on treatment optimization in pediatric patients.

Autor: Hu, Lin¹ (AUTHOR) 1150721071@qq.com, Huang, Shiqiong¹ (AUTHOR), Huang, Qi² (AUTHOR), Huang, Juanjuan¹ (AUTHOR), Feng, Zeying^3,4 (AUTHOR), He, Gefei¹ (AUTHOR) 1150721071@qq.com

Publikováno v: PLoS ONE. 9/11/2023, Vol. 18 Issue 9, p1-12. 12p.